» Articles » PMID: 30237829

Myeloid-derived Suppressor Cells in Non-neoplastic Inflamed Organs

Overview
Journal Inflamm Regen
Publisher Biomed Central
Date 2018 Sep 22
PMID 30237829
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myeloid-derived suppressor cells (MDSCs) are a highly heterogeneous population of immature myeloid cells with immunosuppressive function. Although their function in tumor-bearing conditions is well studied, less is known about the role of MDSCs in various organs under non-neoplastic inflammatory conditions.

Main Body: MDSCs are divided into two subpopulations, G-MDSCs and M-MDSCs, and their distribution varies between organs. MDSCs negatively control inflammation in inflamed organs such as the lungs, joints, liver, kidneys, intestines, central nervous system (CNS), and eyes by suppressing T cells and myeloid cells. MDSCs also regulate fibrosis in the lungs, liver, and kidneys and help repair CNS injuries. MDSCs in organs are plastic and can differentiate into osteoclasts and tolerogenic dendritic cells according to the microenvironment under non-neoplastic inflammatory conditions.

Conclusion: This article summarizes recent findings about MDSCs under inflammatory conditions, especially with respect to their function and differentiation in specific organs.

Citing Articles

Identification of differentially expressed genes, pathways, and immune infiltration in diabetes.

Liang Y, Wei S, Peng X, Feng Q, Li L, Liang D Clinics (Sao Paulo). 2024; 79:100436.

PMID: 39096856 PMC: 11345339. DOI: 10.1016/j.clinsp.2024.100436.


Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.

Fujikawa Y, Sendo S, Del Peral Fanjul A, Yamada H, Uto K, Yamamoto Y Front Immunol. 2024; 15:1168323.

PMID: 38566990 PMC: 10985135. DOI: 10.3389/fimmu.2024.1168323.


Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease.

Surico P, Lee S, Singh R, Naderi A, Bhullar S, Blanco T Exp Eye Res. 2024; 242:109871.

PMID: 38527580 PMC: 11055659. DOI: 10.1016/j.exer.2024.109871.


Extramedullary hematopoiesis in cancer.

Barisas D, Choi K Exp Mol Med. 2024; 56(3):549-558.

PMID: 38443597 PMC: 10985111. DOI: 10.1038/s12276-024-01192-4.


Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products.

Calderon J, Prieto K, Lasso P, Fiorentino S, Barreto A Arch Immunol Ther Exp (Warsz). 2023; 71(1):17.

PMID: 37410164 PMC: 10326112. DOI: 10.1007/s00005-023-00681-0.


References
1.
Yeager M, Nguyen C, Belchenko D, Colvin K, Takatsuki S, Ivy D . Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension. Chest. 2011; 141(4):944-952. PMC: 3318947. DOI: 10.1378/chest.11-0205. View

2.
Young M, Newby M, Wepsic H . Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 1987; 47(1):100-5. View

3.
Arora M, Poe S, Oriss T, Krishnamoorthy N, Yarlagadda M, Wenzel S . TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 2010; 3(6):578-93. PMC: 2958091. DOI: 10.1038/mi.2010.41. View

4.
Roder J, Hickey W . Mouse models, immunology, multiple sclerosis and myelination. Nat Genet. 1996; 12(1):6-8. DOI: 10.1038/ng0196-6. View

5.
Cheng L, Wang J, Li X, Xing Q, Du P, Su L . Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice. PLoS One. 2011; 6(3):e17631. PMC: 3048877. DOI: 10.1371/journal.pone.0017631. View